Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. (2020)

First Author: Folegatti PM

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S0140-6736(20)31604-4

PubMed Identifier: 32702298

Publication URI: http://europepmc.org/abstract/MED/32702298

Type: Journal Article/Review

Volume: 396

Parent Publication: Lancet (London, England)

Issue: 10249

ISSN: 0140-6736